Sara Hover discusses the challenges some patients face when it comes to optimizing thyroid hormone levels. She reveals that there are a few, emerging theories that could help patients with thyroid issues.

二元同步通信,祝贺阿什利·诺兰co-o CPhTwner of Martin's Wellness & Compounding at Lamar Plaza Drug Store in Austin, Texas for being our April Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

To help pharmacies who have struggled and continue to struggle with the challenges brought on by this unprecedented time, we asked six compounding pharmacy owners about how they have successfully steered their practices through the pandemic. Here's what they had to say.

Congratulations to Joseph P. Navarra, RPh, FACA, owner of Town TOTAL Compounding Center in Woodbury, New York for being our March Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

Melissa Merrell Rhoads and Suki Pramar of PCCA discuss selecting the right antimicrobial preservative when compounding medication for patient health challenges.

Nat Jones, one of PCCA's Clinical Compounding Pharmacist, discusses the importance of naltrexone and how compounders can use Low-Dose Naltrexone therapy, especially with dermatological health challenges.

Erin Michael discusses how the Pharmacy Technician of today differs wildly from what the position used to be in terms of responsibilities and opportunities, but also how the position has never been more important.

Matt Martin writes to help compounding pharmacies navigate the Food and Drug Administration’s (FDA’s) recently finalized guidance document Insanitary Conditions at Compounding Facilities.

PCCA's Formulation Development team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a key component of PCCA's abiding desire to provide pharmacies with formulas that alleviate patient health challenges. The Formulation Development Spotlight is a limited series of articles designed to highlight a singular member of the formula development team. This article focuses on Melissa Merrell Rhoads.

PCCA provides clarity and guidance regarding the Food and Drug Administration (FDA) sharing its version of what a memorandum of understanding (MOU) between it and the various states would look like.